Not applicableStudy completedNCT03098589What this trial is testingRevlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)Who this might be right forLymphoma Celgene 1,149
Early research (Phase 1)Looking for participantsNCT05292664What this trial is testingVenetoclax Basket Trial for High Risk Hematologic MalignanciesWho this might be right forMyelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more Andrew E. Place, MD 30
Testing effectiveness (Phase 2)UnknownNCT00003885What this trial is testingArsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Our Lady of Mercy Medical Center 60
Early research (Phase 1)Looking for participantsNCT06326008What this trial is testingSafety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical TrialWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in Relapse Beijing GoBroad Hospital 48
Early research (Phase 1)Study completedNCT01786135What this trial is testingA Safety Study of SGN-CD19A for B-Cell LymphomaWho this might be right forBurkitt LymphomaLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+2 more Seagen Inc. 64
Testing effectiveness (Phase 2)UnknownNCT02965092What this trial is testingCD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaB Cell Lymphoma Wuhan Sian Medical Technology Co., Ltd 80
Testing effectiveness (Phase 2)UnknownNCT01307592What this trial is testingGemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaWho this might be right forLymphoma Auxilio Mutuo Cancer Center 70
Early research (Phase 1)Looking for participantsNCT04872478What this trial is testingPharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia Meryx, Inc. 50
Early research (Phase 1)Study completedNCT00005064What this trial is testingPS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeWho this might be right forAdult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT00290706What this trial is testingA Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University 32
Testing effectiveness (Phase 2)Study completedNCT00474929What this trial is testingSorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 103
Early research (Phase 1)Study completedNCT05563545What this trial is testingAnti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Shanghai Simnova Biotechnology Co.,Ltd. 2
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Early research (Phase 1)Study completedNCT02168140What this trial is testingCPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaWho this might be right forAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+14 more Wake Forest University Health Sciences 16
Very early researchUnknownNCT06393335What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical ResearchWho this might be right forAcute Lymphoblastic LeukemiaNon-hodgkin Lymphoma The Children's Hospital of Zhejiang University School of Medicine 36
Not applicableTemporarily pausedNCT03229876What this trial is testingSafety and Efficacy Evaluation of CD19-UCARTWho this might be right forAcute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL) Bioray Laboratories 20
Early research (Phase 1)Active Not RecruitingNCT02879695What this trial is testingBlinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more National Cancer Institute (NCI) 28
Very early researchActive Not RecruitingNCT06765876What this trial is testingCART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I TrialWho this might be right forLeukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more Institute of Hematology and Blood Transfusion, Czech Republic 18
Early research (Phase 1)Study completedNCT04996160What this trial is testingPalbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia, PediatricRelapsed Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia Tanja Andrea Gruber 2
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241